Empaglif 10 mg (Tablet)
Unit Price: ৳ 30.00 (3 x 10: ৳ 900.00)
Strip Price: ৳ 300.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Aristopharma ltd |
| Also available as |
Indications
- Adjunct to diet and exercise for type 2 diabetes mellitus
- Reduction of cardiovascular death in type 2 diabetes with established cardiovascular disease
Pharmacology
Sodium glucose co-transporter-2 (SGLT-2) inhibitor
Dosage and Administration
Recommended dose of 10 mg once daily, may be increased to 25 mg once daily
Interactions
- Diuretics resulting in increased urine volume
- Increased risk of hypoglycemia with insulin or insulin secretagogues
- SGLT2 inhibitors leading to positive urine glucose tests
- Unreliable 1,5-AG assay for glycemic control
Contraindications
- Serious hypersensitivity reaction to Empagliflozin or its ingredients
- Severe renal impairment
- End-stage renal disease or dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy and Lactation
Use during pregnancy if benefit justifies risk, not recommended during breastfeeding
Precautions and Warnings
Assessment of renal function recommended, not initiated in patients with eGFR less than 45 ml/min/1.73 m2
Overdose Effects
Employ usual supportive measures, hemodialysis not studied for removal
Therapeutic Class
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
Cool & dry place below 30°C, protected from light & moisture, keep out of reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
- Chemical Structure: Image available
Common Questions about Empaglif 10 mg Tablet
- Reduces reabsorption of glucose from kidney
- Improves glycemic control in adults
- May be unsafe to use during pregnancy
- Probably unsafe to use during breastfeeding
- Caution in use for patients with underlying kidney disease
- No dose adjustment needed for mild to moderate liver disease
- Quick Tips available